Will Run Strong to Earnings Aug 3$VBIV continues to amaze. Just when you think the run is over trader propel this stock higher. Following the old adage - "don't fight the trend" we see VBIV continuing to rise into earnings Aug 3 with brief profit taking along the way. Day traders paradise. Longer term...we're talking weeks...expect VBIV to bask in the glow of being the only self described pan coronavirus vaccine which is a pretty powerful concept. And make no mistake, all of these vaccine makers are dealing with conceptual scientific theories on what will work....so right now, VBIV has just as good a shot at fielding a successful vaccine as the rest. Right now in Robinhood land, 220k RHers hold $INO an early darling in the vaccine race. VBIV only has 60k in following. Given VBIV is comparatively less expensive, I expect to see significant inflows of RH monies into VBIV as it continues it march towards earnings and beyond. Target price prior to earnings a conservative $9.92. If the RH gang catches on could go to $15-18 range and test 5 year highs....worth the time. Remember, "the trend is your friend" and in this red hot biotech space "a rising tide lifts all boats".
INO
$AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)see full chart at www.tradingview.com
AZN
Entry $51.68
Target $53
stoploss $50
Why this play?
they are really trying to push the Covid wave 2 case, and the market is crash. so if wave 2 really comes, these stocks should pump even further.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
INO: only going upLooking at the trends and the candle sticks, I think INO is going up for the coming weeks/months. However, all very much depending on the outcome of the ongoing clinical trial: some results leaked and these were moderately positive (clinicaltrials.gov and www.pharmaceutical-technology.com). If the final results are disappointing or negative, it will go down, fast. Otherwise it will get a boost and easily reach over $30 towards $40. In the mean time I expect it to swing around $22-$24.
Wondering what you think?
Disclaimer: am a newbie, so also here to learn. Happy to receive constructive feedback.
Upward TrajectoryAll it will take is a little positive news to sent $INO to new 52 week highs. Lots of news potential in July. Support in low 20s confirmed. MACD about to go green, trend is up. Establish call option position here and add on the way up.
INO may of found its bottom.As you can see from the simple chart below. INO appears to be back on its path of growth it was on before it went Parabolic on the news that the DoD was buying $70m worth of Inovio vaccine injectors. They are submitting their Phase I trial data to peer reviewed journals (as it always does) on Monday. None of the other vaccine candidates in Operation Warp Speed have peer reviewed studies on any of their CVOID19 candidates.
This in combination with being accepted into Operation Warp Speed almost guarantees funding will be coming from Barda or CEPI as every other candidate in OWS has received. What you are seeing here is the MM manipulation knocking out scared retail to buy up the stock. For some context you can see MRNA chart behaved in a near exact way. Peeking at 31 a share on good news of a mouse study before the sell of to ~$18 and then slow steady climb to a ATH $91. INO also behaved in a similar fashion last month on pre-clicincal study where it rocketed the stock to $20 before it sold of back down to $13. This is classic Biotech market behavior.
$INO Turns Sour After Parabolic Squeeze Meets Opaque UpdateINO has been one of the real poster-boys for the so-called Robinhood bubble.
The company is a chronic underperformer in the biotech space with a likely failed vaccine candidate -- given its lack of detail in any update -- powering the action despite the fact that vaccines generally aren't profitable in the first place, and this isn't going to be it. Caution!
$INO Inovio Overbought - RSI Trending Down$INO Inovio Overbought RSI Trending Down
High risk short play, but will likely see a retrace back to March high just under $20.00 in near term.
Note: Not investment advice.
Inovio Trade 29/06/20Inovio NASDAQ:INO performed incredibly well last week due do a $71 grant from the DoD and pending Phase 1 results of INO-4800 which were said to be realeased late June.
Expect a dip, before rising to analysts target of $45.
Fundemental Analysis
1. Dr Fauci announced yesterday evening that positive vaccine results were to be released over the next few days.
2. China and South Korea implementation of Phase 1 which will be funded by CEPI.
3. S. Korea, BARDA and DARPA funding to come.
4. Likely approval from FDA to go onto phase 3 trials when results are confirmed to be positive.
Technical Analysis
1. Volume picking up massively this last week, as RobinHood traders continue to get on board.
2. RSI fallen towards 50 after Fridays slight fall in stock price, giving the stock a chance for another sudden rise in prices.
3. Strong support levels around 27.55 and 23.51
INO BACK TO $16-18yo yo
alright so it broke out the past two days because they received funding for COVID testing. So the rally happened and if you got in that's awesome. The RSI indicates that it is overbought. My expectation is that it sells tomorrow (June 25) and goes back down to around 16-18. If it hits 15$ and bounces back up then that's a good indication that it should come back up! Don't buy yet. it is at the top. second support is 11$
anything can happen so just keep an eye on it !
good luck
trade smart.
:)
$INO IdeaWatched at $20 and it went up to $21.28 and beyond. Thanks to a friend, keeping me posted, it was a good look if they got in at the $20....
I believe its going to be shorted like $UONE for a good day then rally back up so, Imma keep a eye on this pull back.
Maybe to 19 or 20 dollars?
[INO] Technically Oversold but Coronavirus Stocks are VolatileINO's narrow, steep channel makes no sense, it'll break below channel line and correct into new downward channel likely falling along with overall market in June.
Avg. cost: $7.28
Sold 20% at $11.63 (~50% profit mark), 20% at $13.30 (~100% profit mark) and 20% at $16.09 today (rough peak estimate). Will hold the remaining 40% just cuz who knows if some trial or study or funding announcement drops but I do expect it to fall back down and would love a chance to re-up here around $10. Even POC (white line) of $13 is probably still a bit overpriced. Dripping in FOMO here.
INO ready for new highI have taken a long position in INO here.
INO is in human trials for covid-19 vaccine with safety results expected in late June. Multiple possible catalyst including further funding. NVAX just received $388 million from CEPI and with INO being one of the few in human trials for covid-19 vaccine already, further funding for INO is likely as well.
This is not a recommendation to buy.
This is not financial advice.
INO more chart dataDepending channel, typically bullish, but will likely head further south. May not be all the way to the diagonal support line. We shall see.
INO inverse H&S heading to diagonal resistance LONGInverse H&S heading into diagonal resistance that has been tested four times previously. I've been holding this as a value play, but it seems as if technically-speaking, it will break out soon. Obviously, pay attention to the markets as a whole, don't bet the farm on it ;-p. Not financial advice.
[NVAX] Sliding Back to $40, Collapse if It Breaks ThroughI missed this guy when I jumped on MRNA and INO earlier this week.
Just trying to pin this one down a bit, coronavirus stocks are wild and fun :).
For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile.
Support should be right around the POC, which is $40.
It should slide down to that and hang a bit before breaking through and crashing down. May bounce back up too but seems unlikely.
All indicators are lining up at the start of a downward channel and signaling a short move too.
June market crash is probably gonna move this more than anything as retail tries to secure their tiny profits or stem their massive losses.
INO has more than Covid going for it!Hello all! I will like to disclose that I have been an early investor in INO since 2008! So unlike a lot of others that are new to Inovio, I really know this company well. Do not listen to CITRON as they are speaking from ignorance and not knowing anything at all about what a company like INO does or is about. \
That been said... I have been keeping a close watch on develop.60ments from INO, they have a whole lot going for them. What people don't realize is that to run such an innovative company it requires burning through a lot of cash. They have nothing out in the market right now but a whole lot already in the pipeline. I really do believe INO is one positive result news away from getting to new highs. We are looking at $15 here if we can break and get outta that zone it be off to new highs. I believe we would have already hit new highs if not for the timing of that horrible Citron research article.
Strong support around the $8 area but I don't feel like we will go that low. If we do I would accumulate even more there.
To me, no other vaccine company has more upside than INO. Keep in mind this is all speculative and nothing is guaranteed.
Nothing looks shaky about INO in fact I would argue that it has been holding up very well even with the FUDI am looking at $15.60 area as the next area we need to break and stay above to continue to get to new highs.
The truth is I can't and no one can give you a target for INO.
Trade wisely my friends
INO longGood news with pop. May need to drop to diagonal resistance turned support for next leg up, or may be able to with horizontal support at previous high.
TEVA short-term shortMore optimistic over 1/1 Gann fan, bullish over 2/1 and back into channel and above resistance. Overall nice medium term reversal pattern.
INO going down, major resistanceFib levels are acting as strong support and resistance, is likely to start going down the fib ladder like a basketball.
Also we have a trendline resistance from the last few weeks.
